Pulse Biosciences (PLSE) Return on Sales (2021 - 2025)

Pulse Biosciences' Return on Sales history runs 4 years deep, the most recent figure standing at 3.48% for Q3 2025.

• On a quarterly basis, Return on Sales changed N/A year-over-year to 3.48% in Q3 2025; TTM through Sep 2025 was 2.54%, a N/A change from a year earlier, with the FY2022 full-year figure at 0.84%, down 38.0% from the prior year.
• Return on Sales retreated to 3.48% in Q3 2025 per PLSE's latest filing, from 1.93% in the prior quarter.
• Across five years, Return on Sales topped out at 0.19% in Q4 2021 and bottomed at 3.48% in Q3 2025.
• The 4-year median for Return on Sales is 0.48% (2022), against an average of 1.0%.
• Across the five-year window, Return on Sales declined 16 bps in 2022 and slumped 154 bps in 2023, its largest moves.
• Year by year, Return on Sales stood at 0.19% in 2021, then tumbled by 341 bps to 0.83% in 2022, then plunged by 133 bps to 1.93% in 2023, then tumbled by 81 bps to 3.48% in 2025.
• Per Business Quant, the three latest PLSE Return on Sales figures stand at 3.48% (Q3 2025), 1.93% (Q1 2023), and 0.83% (Q4 2022).